Literature DB >> 8892768

Thrombolytic enhancement with perfluorocarbon-exposed sonicated dextrose albumin microbubbles.

T R Porter1, R F LeVeen, R Fox, A Kricsfeld, F Xie.   

Abstract

Whereas low-intensity, high-frequency ultrasound (US) alone appears to cause minimal thrombolysis, US combined with air-filled microbubbles does increase the amount of urokinase (UK)-mediated clot lysis (CL). Because this phenomenon may be mediated by cavitation-induced streaming, we hypothesized that perfluorocarbon-exposed sonicated dextrose albumin (PESDA) microbubbles, which are more stable than air-filled microbubbles, may also enhance US-induced thrombolysis. We measured the percentage CL of equally sized thrombi (1.0 +/- 0.1 mg) made from freshly drawn blood incubated for 2 hours and then exposed to 20 kHz US (0.846 MPa peak negative pressure). The thrombi were bathed in 4 ml of saline solution, UK alone (20,000 U), PESDA alone, or a combination of PESDA with UK. The percentage CL achieved with PESDA and therapeutic US was also compared with the percentage CL achieved with room air-filled sonicated dextrose albumin (RASDA) microbubbles. When compared with US alone (24% +/- 13% CL) or UK alone (17% +/- 3% CL), PESDA plus US produced significantly better CL (43% +/- 17%; p< 0.05). PESDA combined with US also produced significantly greater CL than RASDA combined with US (28% +/- 9%; p < 0.05). The optimal CL was achieved with a combination of PESDA with UK with US (60% +/- 14% CL). We conclude that PESDA microbubbles alone may be capable of inducing thrombolysis when insonified with a low-frequency transducer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8892768     DOI: 10.1016/s0002-8703(96)90006-x

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  35 in total

1.  Cooling System Permits Effective Transcutaneous Ultrasound Clot Lysis In Vivo Without Skin Damage.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998-09       Impact factor: 2.300

Review 2.  Section 8--clinical relevance. American Institute of Ultrasound in Medicine.

Authors: 
Journal:  J Ultrasound Med       Date:  2000-02       Impact factor: 2.153

Review 3.  Section 6--mechanical bioeffects in the presence of gas-carrier ultrasound contrast agents. American Institute of Ultrasound in Medicine.

Authors: 
Journal:  J Ultrasound Med       Date:  2000-02       Impact factor: 2.153

Review 4.  Section 7--discussion of the mechanical index and other exposure parameters. American Institute of Ultrasound in Medicine.

Authors: 
Journal:  J Ultrasound Med       Date:  2000-02       Impact factor: 2.153

Review 5.  Section 4--bioeffects in tissues with gas bodies. American Institute of Ultrasound in Medicine.

Authors: 
Journal:  J Ultrasound Med       Date:  2000-02       Impact factor: 2.153

Review 6.  Ultrasonic drug delivery--a general review.

Authors:  William G Pitt; Ghaleb A Husseini; Bryant J Staples
Journal:  Expert Opin Drug Deliv       Date:  2004-11       Impact factor: 6.648

7.  The application of sparse arrays in high frequency transcranial focused ultrasound therapy: a simulation study.

Authors:  Daniel Pajek; Kullervo Hynynen
Journal:  Med Phys       Date:  2013-12       Impact factor: 4.071

8.  Volumetric quantification of in vitro sonothrombolysis with microbubbles using high-resolution optical coherence tomography.

Authors:  Jong S Kim; Jonathan E Leeman; Larry Kagemann; Francois T H Yu; Xucai Chen; John J Pacella; Joel S Schuman; Flordeliza S Villanueva; Kang Kim
Journal:  J Biomed Opt       Date:  2012-07       Impact factor: 3.170

Review 9.  Microbubbles in ultrasound-triggered drug and gene delivery.

Authors:  Sophie Hernot; Alexander L Klibanov
Journal:  Adv Drug Deliv Rev       Date:  2008-04-03       Impact factor: 15.470

10.  Production of uniformly sized serum albumin and dextrose microbubbles.

Authors:  Michael J Borrelli; William D O'Brien; Laura J Bernock; Heather R Williams; Eric Hamilton; Jonah Wu; Michael L Oelze; William C Culp
Journal:  Ultrason Sonochem       Date:  2011-05-27       Impact factor: 7.491

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.